openPR Logo
Press release

Analyzing the trends and forecasting Global Infectious Disease Therapeutics Market (2016-2021)

06-27-2017 08:03 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Market Data Forecast

Market Data Forecast

Market Data Forecast

According to the report “Global Infectious Disease Therapeutics Market,” published by Market Data Forecast, the global market is projected to reach USD 132.29 million by 2021 from USD 90.2 billion in 2016, at a CAGR of 7.96%.

Infectious diseases remain the leading cause of death of children worldwide. New therapeutics are urgently needed, to replace current treatments that are being compromised by resistance phenomena, and to combat emerging threats.

More recently, institutional initiatives in structural biology and chemical biology have brought expertise in structure-based drug discovery, high throughput screening and medicinal chemistry. The broad goals of the research in this field are to characterize the pathogenic mechanisms of micro-organisms, to identify suitable targets for therapeutic intervention, and to develop vaccines and lead drug compounds into safe and effective medicines.

Request Free Sample: http://www.marketdataforecast.com/market-reports/global-infectious-Disease-therapeutics-market-1320/request-sample

The factors influencing the Global Market for Infectious Disease Therapeutics Market, either positively or negatively are presented in the DROC analysis. Major factors that are driving the growth of the market are increasing occurrence of infectious diseases, growing use of direct acting anti-viral, increasing health care expenditure and increasing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries. The major factor restraining the growth of the market is generic erosion, Patent expiration of infectious disease drugs.

Customize Report: http://www.marketdataforecast.com/market-reports/global-infectious-Disease-therapeutics-market-1320/customize-report

For granular level understanding, the Infectious Disease Therapeutics Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segments.

1) By Mode of Treatment
• Drugs
• Oral Administration
• Topical
• Injections
• Others
• Vaccines

2) By Target Organism
• Antibacterial
• Antifungal
• Antiviral
• Antiparasite
• Others

3) By Infection type
• Bacterial
• Viral
• Fungal
• Parasitic
• Others

4) By Distribution Channels
• Hospitals
• Clinics
• Others

Inquire Before Buying: http://www.marketdataforecast.com/market-reports/global-infectious-Disease-therapeutics-market-1320/inquire

Based on Geography, the Infectious disease therapeutics market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to account the highest share in the market followed by Asia-Pacific and Europe owing to rising incidence of infectious diseases, and increasing aging population. Asia-Pacific is projected to account the highest CAGR over the forecast period owing to increasing government funding in some emerging countries such as India, China.

• North America Infectious Disease Therapeutics Market
• Europe Infectious Disease Therapeutics Market
• Asia-Pacific Infectious Disease Therapeutics Market
• Latin America Infectious Disease Therapeutics Market
• Middle East and Africa Infectious Disease Therapeutics Market

Request Discount: http://www.marketdataforecast.com/market-reports/global-infectious-Disease-therapeutics-market-1320/request-discount

Some of the major companies operating in global Infectious disease Therapeutics Market F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Sanofi.

Buy now: http://www.marketdataforecast.com/cart/buy-now/global-infectious-Disease-therapeutics-market-1320

The Infectious Disease Therapeutics Market study offers the following deliverables:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
• A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Therapeutics Segment:

Clinical Nutrition Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market- reports/global-clinical- nutrition-market- 785/

Cervical Cancer Diagnostics and Therapeutics Market: http://www.marketdataforecast.com/market-reports/global- cervical-cancer- diagnostics-and-therapeutics- market-829/

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Analyzing the trends and forecasting Global Infectious Disease Therapeutics Market (2016-2021) here

News-ID: 596922 • Views:

More Releases from Market Data Forecast

Business Management Consulting Service Market is expected to witness a significant growth rate
Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024. The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations
Antimicrobial Coatings Market expected to witness a significant growth rate of 11% by 2029.
Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029. It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively
End-User Computing Market Sees Explosive Growth Globally
End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period. Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user
Smart Homes Market Size, Share, Growth Report 2024-2029
Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period. Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and